不同胃癌负担国家胃癌前病变的患病率:系统评价与Meta分析
该系统评价与Meta分析纳入166项研究,估计全球萎缩性胃炎、肠上皮化生和异型增生患病率分别为25.4%、16.2%和2.0%;所有癌前病变在高、中胃癌发病率国家高于低发病率国家(P<.01),幽门螺杆菌感染者萎缩性胃炎和肠上皮化生患病率显著更高(P<.01),而有症状与无症状个体间无统计学差异(P>.17),所有癌前病变患病率随时间呈下降趋势。
要点
- 全球萎缩性胃炎、肠上皮化生和异型增生患病率分别为25.4%、16.2%和2.0%。
- 高、中胃癌发病率国家所有癌前病变患病率均高于低发病率国家(P<.01)。
- 有症状与无症状个体癌前病变患病率无统计学差异(P>.17)。
核心结论
- 胃癌前病变患病率在不同胃癌发病率地区存在差异,且与幽门螺杆菌感染相关。
- 由于癌前病变在有症状和无症状个体中均有相当患病率,仅对有症状者进行评估可能不足以识别高危个体。
- 这些估计为制定胃癌预防策略提供了重要参考。
研究设计与样本
- 系统评价与Meta分析,最终纳入166项研究。
主要发现
- 全球萎缩性胃炎、肠上皮化生和异型增生的患病率估计分别为25.4%、16.2%和2.0%,基于126项报告较轻癌前病变(不论是否存在更晚期病变)患病率的研究。
- 所有癌前病变的患病率在高、中胃癌发病率国家高于低发病率国家(P<.01)。
- 萎缩性胃炎和肠上皮化生的患病率在幽门螺杆菌感染者中显著更高(P<.01),但在有症状与无症状个体间无统计学差异(P>.17)。
- 所有癌前病变的患病率随时间呈下降趋势。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND & AIMS: The prevalence of precursor lesions for gastric cancer (GC) and the differential burden between countries of varying GC risk is not well-understood. We conducted a systematic review and meta-analysis to estimate the global prevalence of precursor lesions. METHODS: We estimated the prevalence of atrophic gastritis (AG), gastric intestinal metaplasia (IM), and dysplasia in regions with low, medium, and high GC incidence. Because IM is an advanced manifestation of AG, we assessed the prevalence of less advanced precursors, regardless of the presence of more advanced lesions. Prevalence was sub-stratified by Helicobacter pylori infection, symptomatology, and period (<2000, 2000-2010, and >2010). RESULTS: Among the 582 articles that underwent full-text review, 166 studies met inclusion criteria. The global prevalence estimates of AG, IM, and dysplasia were 25.4%, 16.2%, and 2.0%, respectively, on the basis of 126 studies that reported the prevalence of less advanced precursors, regardless of the presence of more advanced lesions. The prevalence of all precursor lesions was higher in high and medium compared with low GC incidence countries (P < .01). Prevalence of AG and IM was significantly higher among H pylori-infected individuals (P < .01) but not statistically different between symptomatic and asymptomatic individuals (P > .17). All precursors demonstrated a secular decrease in prevalence over time. CONCLUSIONS: Gastric precursor lesions have differences in prevalence in regions with differential GC incidence and are associated with H pylori infection. Because of the substantial prevalence of precursor lesions in both symptomatic and asymptomatic individuals, symptomatic evaluation may not be sufficient to identify individuals at risk. These estimates provide important insights for tailoring GC prevention strategies.
引用
- Mülder DT, Hahn AI, Huang RJ, et al. Prevalence of Gastric Precursor Lesions in Countries With Differential Gastric Cancer Burden: A Systematic Review and Meta-analysis. Clin Gastroenterol Hepatol. 2024. PMID: 38438000. doi:10.1016/j.cgh.2024.02.023
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。